Global markets were on edge yesterday as President Trump’s newly announced 15% global tariff triggered a sharp European response and fresh trade uncertainty. Equity markets across both Europe and the US struggled, with tech stocks hit particularly hard amid renewed concerns about AI disruption in the software sector. Defensive names, meanwhile, benefited from the flight to safety, alongside a strong move in gold. Asian markets painted a mixed picture. On today’s show, we are joined by Next Generation research analyst Damien Ng who shares an update on the implications of the emerging Alzheimer’s blood test and what it means for the genomics space.
- (00:00) - Introduction: Bernadette Anderko, Product & Investment Content
- (00:34) - Markets wrap-up: Lucija Caculovic, Product & Investment Content
- (06:17) - Alzheimer's blood test impact on Genomics: Damien Ng, Next Generation Research
- (11:25) - Closing remarks: Bernadette Anderko, Product & Investment Content
Would you like to support this show? Please leave us a review and star rating on Apple Podcasts, Spotify or wherever you get your podcasts.
